Page 161 - Tata_Chemicals_yearly-reports-2020-2021
P. 161

Integrated Report   Statutory Reports  Financial Statements
              1-59                60-146             Standalone



            Standalone Statement of Profit and Loss for the year ended March 31, 2021
                                                                                                        ` in crore
                                                                                         Year ended   Year ended
                                                                                 Note
                                                                                       March 31, 2021  March 31, 2020
             I.  Incomes
                 a)   Revenue from operations                                     25        2,998.88    2,920.29
                 b)   Other income                                                26         219.15      309.15
                 Total income (a+b)                                                        3,218.03     3,229.44
             II.  Expenses
                 a)   Cost of materials consumed                                             600.33      541.90
                 b)   Purchases of stock-in-trade                                            152.56       94.41
                 c)   Changes in inventories of finished goods, work-in-progress and stock-in-trade  27  11.59  (76.41)
                 d)   Employee benefits expense                                   28         250.42      250.28
                 e)   Finance costs                                               29          18.74       43.37
                 f)   Depreciation and amortisation expense                       30         197.32      149.50
                 g)   Other expenses                                              31        1,373.10    1,392.07
                 Total expenses (a to g)                                                   2,604.06     2,395.12
             III.  Profit before tax ( I - II )                                             613.97       834.32
             IV.  Tax expense
                 (a)   Current tax                                                33         134.49      194.37
                 (b)   Deferred tax                                               33           0.37      (31.87)
                 Total tax expense (a+b)                                                    134.86       162.50
             V.  Profit for the year from continuing operations ( III-IV)                   479.11       671.82
             VI.  Exceptional gain from discontinued operations (net)             34             -      6,128.08
             VII.  Tax expense of discontinued operations                         34             -       (40.32)
             VIII. Profit for the year from discontinued operations ( VI-VII)                    -      6,168.40
             IX.  Profit for the year (V+VIII)                                              479.11      6,840.22
             X.  Other comprehensive income (net of tax) ("OCI") - gain/(loss)
                 (A)   Items that will not be reclassified to the Statement of Profit and Loss
                     -   Changes in fair value of investments in equities carried at fair value through OCI  1,194.26  (557.31)
                     -   Remeasurement of defined employee benefit plans (note 38)            28.72      (50.55)
                 (B)   Income tax relating to items that will not be reclassified to the Statement of Profit and Loss  142.01  (65.42)
                 Total other comprehensive income - gain/(loss) (net of tax) (A-B)         1,080.97     (542.44)
             XI.  Total comprehensive income for the year (IX+X)                           1,560.08     6,297.78
             XII.  Earnings per share for continuing operations (in `)
                 -   Basic and Diluted                                            35          18.81       26.37
             XIII. Earnings per share for discontinued operations (in `)
                 -   Basic and Diluted                                            35             -       242.13
             XIV. Earnings per share (for continuing and discontinued operations) (in `)
                 -   Basic and Diluted                                            35          18.81      268.50
                 Notes forming part of the Standalone Financial Statements       1-46
             As per our report of even date attached             For and on behalf of the Board
             For B S R & Co. LLP                                 N. Chandrasekaran    Chairman
             Chartered Accountants                               (DIN: 00121863)      Director
                                                                 Padmini Khare Kaicker
             Firm's Registration No: 101248W/W - 100022          (DIN: 00296388)
                                                                 R. Mukundan          Managing Director and CEO
             Vijay Mathur                                        (DIN: 00778253)
             Partner                                             Nandakumar S. Tirumalai  Chief Financial Officer
             Membership No. 046476                               (ICAI M. No.: 203896)  General Counsel & Company Secretary
                                                                 Rajiv Chandan
             Mumbai, May 3, 2021                                 (ICSI M. No.: FCS 4312)

                                                                                                           159
   156   157   158   159   160   161   162   163   164   165   166